Android app Apple app link

Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge

By Yahoo! Finance   |   1 month ago
Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge

Eli Lilly's strong quarter, driven by successful diabetes and weight-loss drugs, exceeded expectations. The company raised its revenue outlook for 2025. Shares rose 5% in premarket trading, as investors anticipate continued success in the growing GLP-1 market.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.